[en] Several lines of evidence suggest a role for dopamine in the pathophysiology of depression. In 1988, we reported a blunted response of growth hormone (GH) to apomorphine, a dopaminergic agonist, in endogenous depression. However, an antidepressant washout period is a major confounding factor in studies assessing the GH response to apomorphine. Indeed, whereas the influence of tricyclic antidepressants on the GH response to apomorphine is presently unknown, several reports have suggested that tricyclics may impair the GH response to clonidine for periods longer than 3 weeks following their discontinuation. In the present study, we hypothesized that a blunted GH response to apomorphine in depressed patients could be related to the recent administration of antidepressants. Therefore, the GH response to apomorphine (0.5 mg) was studied in 11 male DSM-III-R major depressive inpatients who had never received antidepressant therapy (group 1) compared to 11 normal controls and 11 major depressive inpatients drug free for at least 2 weeks (group 2). The three groups differed significantly in the GH peak response to apomorphine: mean (SD) 5.4 (4.0) ng/ml in group 1, 25.5 (10.7) in normal controls, and 5.5 (5.1) in group 2 (F = 15.5, df = 3, 30, p = 0.00001). While group 1 and normal controls (F = 21.8, p = 0.0002) as well as group 2 and controls (F = 5.6, p = 0.03) differed significantly, group 1 and group 2 did not (F = 0.18, p = 0.68). These results suggest that a washout period of 2 weeks could be sufficient in studies assessing the GH response to apomorphine.
Disciplines :
Psychiatry
Author, co-author :
Pitchot, William ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
Hansenne, Michel ; Université de Liège - ULiège > Département des sciences cognitives > Psycho. de la personnalité et des différences individuelles
Gonzalez Moreno, Antonio; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
Ansseau, Marc ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
Language :
English
Title :
Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
Kapur S, Mann JJ: Role of the dopaminergic system in depression. Biol Psychiatry 1992;32: 1-17.
Pitchot W, Gonzalez Moreno A, Hansenne M, Wauthy J, Ansseau M: Rôle du systeme dopa-minergique dans la dépression: Corrélats clini-ques du test à l'apomorphine. Acta Psychiatr Belg 1993;93:343-358.
Randrup A, Munkvad I, Fog R: Mania, depression, and brain dopamine; in Essman WB, Val-zelli L (eds): Current Developments in Psychopharmacology. New York, Spectrum Publications, 1975, pp 207-229.
Checkley SA: Neuroendocrine tests of monoamine function in man: A review of basic theory and its application to the study of depressive illness. Psychol Med 1980;10:35-53.
Ansseau M, von Frenckell R, Cerfontaine JL, Papart P, Franck G, Timsit-Bcrthier M, Gee-nen V, Legros JJ: Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. Br J Psychiatry 1988; 153:65-71.
Pitchot W, Hansenne M, Gonzalez Moreno A, Ansseau M: Suicidal behavior and growth hormone response to apomorphine test. Biol Psychiatry 1992:31:1213-1219.
Corn T, Thompson C, Checkley SA: Effects of desipramine treatment upon central adrenore-ceptor function in normal subjects. Br J Psychiatry 1984,145:139-145.
Schittecatte M, Charles G, Machowski R, Wil-motte J: Tricyclic washout and growth hormone response to clonidine. Br J Psychiatry 1989;154:858-863.
Laakmann G: Psychopharmacoendocrinology and depression research. Berlin, Springer, 1990.
Franchimont P: Le dosage radio-immunologi-que de l'hormone de croissance humaine. Cah Méd Lyonnais 1968;44:887-898.
Lai S, Martin JB: Neuroanatomy and neuro-pharmacological regulation of neuroendocrine function; in Van Praag HM, Lader MH, Ra-faelsen OJ, Sachar EJ (eds): Handbook of Biological Psychiatry. III. Brain Mechanisms and Abnormal Behavior-Genetics and Neuroendocrinology. New York, Dekker, 1980.
Hyttel J, OveroKF, Arnt J: Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT uptake inhibitor, citalopram. Psvchopharmacology 1984;83:20-27.
Klimek V. Nielsen M: Chronic treatment with antidepressants decreases the number of [3H]-SCH 23390 binding sites in rat striatum and limbic system. Eur J Pharmacol 1987; 139:163-169
Schittecatte M, Charles G, Nefve C, Garcia Valentin J, Machowski R, Wilmotte J: Longterm downregulation of central adrenoreceptor function by desipramine treatment: A clonidine study in normal subjects. Biol Psychiatry 1992;3:856-858.